Icosavax, Inc.

The momentum for this stock is not very good. Icosavax, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Icosavax, Inc..

News

AstraZeneca completes $1.1B acquisition of UW spinout Icosavax

BizJournals.com - Nat'l Business News Icosavax is targeting viruses that can cause severe respiratory infection.\n more…

AstraZeneca completes $1.1B acquisition of Univ. of Washington biotech spinout Icosavax

GeekWire Biotech giant AstraZeneca has completed its $1.1 billion acquisition of Icosavax, a Seattle-based spinout from the University of Washington's Institute for Protein Design...\n more…

Reviewing Bavarian Nordic A/S (OTCMKTS:BVNRY) & Icosavax (NASDAQ:ICVX)

Ticker Report Bavarian Nordic A/S (OTCMKTS:BVNRY Get Free Report) and Icosavax (NASDAQ:ICVX Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare...\n more…

Icosavax: Tender Offer With Contingent Value Right

SeekingAlpha Icosavax: Tender Offer With Contingent Value Right...\n more…

Adam K. Simpson Sells 15,000 Shares of Icosavax, Inc. (NASDAQ:ICVX) Stock

Zolmax Icosavax, Inc. (NASDAQ:ICVX Get Free Report) CEO Adam K. Simpson sold 15,000 shares of the firms stock in a transaction that occurred on Thursday, February 1st. The shares were sold at...\n more…

Icosavax (NASDAQ:ICVX) Sees Unusually-High Trading Volume

Zolmax Icosavax, Inc. (NASDAQ:ICVX Get Free Report) saw unusually-high trading volume on Friday . Approximately 382,110 shares changed hands during mid-day trading, a decline of 46% from the...\n more…